Kay Hagan actually said...

One complaint that I continue to hear from constituent companies is that the FDA's medical device review process is unpredictable and inconsistent.

Hagan expresses concerns about the FDA's review process for medical devices.

11/14/2011

More Kay Hagan Quotes

it certainly shows the efficacy of planning and then carrying it out, and building those relationships.

if these children are not born in a hospital setting, and if a midwife does the test, what is the best time to actually do that test?

The law required the CDC to write a national contingency plan with instructions for how to react in those instances.

Obviously, when you look at these fees compared to any sort of treatment, we know that the screening must take place.